Celularity founder and CEO Robert Hariri appeared on "Power Hour" for an exclusive interview Tuesday.
Click here to listen to the interview.
Celularity went public via special purpose acquisition company GX Acquisition Corp. on July 16.
Celularity focuses on delivering cellular medicines derived from the postpartum human placenta, Hariri told Benzinga.
Sculley is a founding director and vice chairman of the board at Cellularity.
Hariri said he's fortunate to work on the noble pursuit of transforming living cells into medicine with Sculley. Hariri went on to talk more about Sculley, an award he received from Pope Francis and more.
See the full interview here:
Key Highlights:
CELU Price Action: Celularity shares closed at $11.05 Tuesday.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
